The Pfizer Clinical Research Unit in New Haven is seeking healthy volunteers for a clinical trial of a study drug for type 2 diabetes. This study will compare different oral forms of the study drug when taken with or without food.
Type 2 diabetes (T2D) is a chronic disease that occurs when a person’s body does not make or use insulin effectively to regulate blood sugar. Despite the availability of multiple treatments, approximately half of people diagnosed with T2D are not at their blood sugar goal, and more people are diagnosed every day. Pfizer aims to identify and develop breakthrough treatments for people with this disease.
Read more about this study below and learn how you can make a difference as a healthy volunteer.
Who may participate
As a healthy clinical trial participant, you are at the center of drug discoveries that could help patients around the world.
This study is seeking healthy adult volunteers, meaning that the participants will not have the condition being studied and are in overall good health. In addition to the criteria listed, participants must meet the following requirements:
- Willing to take a study drug
- Willing and able to come to our facility in New Haven, CT*
- Willing and able to comply with all study procedures
*participants may be eligible to receive a bonus for travel, ask our staff for details
**females must be unable to bear children
There are other requirements for participation in this study. The study staff will explain these to you during the screening process.
Do you know someone who may meet these requirements? Refer a friend and you may be eligible to receive a bonus.
Condition
Healthy
Age
18+ years
Sex
All sexes**
Referral bonus
Up to $175
Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.
What to expect
If this study may be a fit for you, you’ll be invited to a screening visit at our facility in New Haven, CT. If you qualify for the study, there may be a period of up to 28 days before dosing.
If you choose to participate, you will stay at our facility for 16 consecutive overnights. On the morning after admission and every 3rd morning afterwards, you will receive a single dose of the study drug as a tablet to swallow, for a total of up to 5 doses. The study drug will either be an immediate release (shorter acting) or a modified release (longer acting) formulation. You may receive these doses with or without food.
Throughout the study, staff will closely monitor your health status and collect data, such as the levels of the study drug in your blood.
All of the study procedures will be clearly explained to you during screening and can be viewed by downloading the informed consent form.
Required overnight stays
16
Long-term follow up
1 phone call
How long is this study?
About 44 days
Compensation
Up to $5,530 upon completion of the study
The PCRU Loyalty Program has arrived!
Our new Loyalty Program offers unique tiered gifts for new and returning participants.
Interested in participating?
Complete and submit this form, and a Pfizer New Haven Clinical Research Unit (PCRU) representative will contact you. Please note: volunteers completing this form must be able to read and speak English at an 8th grade level.
You may also call 1-800-254-6398 and speak with a PCRU representative to learn more.
For Japanese language assistance only, please call 1-833-711-9984. We apologize, our representatives cannot take calls in languages other than English or Japanese at this time.
The personal data gathered here will be collected, processed, and maintained in a confidential manner. Your information will be stored in our research unit’s database. We may use this information to invite you to participate in current and future clinical studies at the PCRU. You will have full access to your records at the Pfizer New Haven Clinical Research Unit and the opportunity to correct them if necessary.